Facebook Linkedin RSS Twitter Youtube
Home 2022

Phase II clinical trials (Drug development)

Malaria Drug Could Combat Head and Neck Cancer Chemotherapy Resistance
Cancer

Malaria Drug Could Combat Head and Neck Cancer Chemotherapy Resistance

Researchers Discover a Way to Predict Kidney Cancer’s Response to Immunotherapy
Cancer

Researchers Discover a Way to Predict Kidney Cancer’s Response to Immunotherapy

Heart of the Deal: Prothena Executives on the $1.2B Sale of ATTR Amyloidosis Candidate to Novo Nordisk
Drug Discovery

Heart of the Deal: Prothena Executives on the $1.2B Sale of ATTR Amyloidosis Candidate to Novo Nordisk

Annovis Bio Plans to Build on Alzheimer’s Clinical Trial Positive Results
Insights

Annovis Bio Plans to Build on Alzheimer’s Clinical Trial Positive Results

AbCellera, Lilly Advance Next-Generation Antibody vs. COVID-19
Coronavirus

AbCellera, Lilly Advance Next-Generation Antibody vs. COVID-19

Epizyme Charts Five-Year Clinical Vision, Seeing Silver Linings Amid Tazverik Clouds
Cancer

Epizyme Charts Five-Year Clinical Vision, Seeing Silver Linings Amid Tazverik Clouds

Anima Biotech Heads for the Light with Up-to-$2.4B Takeda Partnership
Drug Discovery

Anima Biotech Heads for the Light with Up-to-$2.4B Takeda Partnership

Breathe In: Theravance Reports Positive Phase II Data for JAK Inhibitor
Coronavirus

Breathe In: Theravance Reports Positive Phase II Data for JAK Inhibitor

AstraZeneca-Oxford COVID-19 Vaccine Shows Positive Phase II Results
Coronavirus

AstraZeneca-Oxford COVID-19 Vaccine Shows Positive Phase II Results

Immune-Boosting Components Double the Effectiveness of Melanoma Vaccine Candidate in Phase II Trial
Cancer

Immune-Boosting Components Double the Effectiveness of Melanoma Vaccine Candidate in Phase II Trial

1...345...61Page 4 of 61
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.